Targeting the estrogen receptor and HER2 pathways improved progression-free survival in patients with HR-positive, HER2-positive metastatic breast cancer. Findings from a recent clinical trial ...

Please provide your email address to receive an email when new articles are posted on . “I think we need to start looking at our treatments for wet AMD in more of a multimodal fashion, attacking it ...

Multimorbidity (MM), the presence of two or more chronic conditions, is increasingly common in clinical practice. Recent studies from India report a prevalence ranging from 28.3% to 45.4% across ...